Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:45 pm Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA CAPITAL MANAGEMENT L.P. | 7,040,622 9.6% | 2,075,034 (+41.79%) | View |
| 2023-02-14 4:23 pm Sale | 13G | Day One Biopharmaceuticals, Inc. DAWN | Atlas Venture Fund XI L.P. | 6,008,534 8.2% | -1,201,708 (-16.67%) | View |
| 2023-02-09 09:59 am Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 9,002,310 12.239% | 693,136 (+8.34%) | View |
| 2023-02-03 5:06 pm Unchanged | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 0 0% | 0 (Unchanged) | View |
| 2022-11-02 4:15 pm Sale | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 2,548,403 3.5% | -2,200,000 (-46.33%) | View |
| 2022-10-19 5:29 pm Sale | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 4,748,403 6.5% | -2,215,898 (-31.82%) | View |
| 2022-09-22 11:06 am Sale | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 6,964,301 9.5% | -2,338,998 (-25.14%) | View |
| 2022-09-19 2:02 pm Sale | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 9,303,299 12.7% | -360,346 (-3.73%) | View |
| 2022-09-12 11:13 am Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | FMR LLC | 8,309,174 11.31% | 8,309,174 (New Position) | View |
| 2022-06-21 4:44 pm Purchase | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 10,684,638 14.55% | 1,306,862 (+13.94%) | View |
| 2022-02-11 5:03 pm Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | Atlas Venture Fund XI L.P. | 7,210,242 11.6% | 7,210,242 (New Position) | View |
| 2022-01-14 06:02 am Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 6,012,758 9.7% | 6,012,758 (New Position) | View |
| 2021-12-22 4:39 pm Sale | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 9,663,645 15.6% | -1,072,000 (-9.99%) | View |
| 2021-06-10 4:13 pm Purchase | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 10,735,645 17.3% | 10,735,645 (New Position) | View |
| 2021-06-09 3:43 pm Purchase | 13D | Day One Biopharmaceuticals, Inc. DAWN | AI Day1 LLC | 9,377,776 15.1% | 9,377,776 (New Position) | View |
| 2021-06-07 4:48 pm Purchase | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA CAPITAL MANAGEMENT L.P. | 4,965,588 8% | 4,965,588 (New Position) | View |